Company: BSAAR
Filing Date: 2025-05-27
Form Type: S-1/A
Source: 0001213900-25-047458
Chunk: 60

Company: BEST SPAC I Acquisition Corp.
Filing Date: 2025-05-27
Form: S-1/A
Chunk 60
---
 sponsor of 206,250 founder shares. (2)Consists solely of founder shares and includes up to 206,250 Class B ordinary shares that are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over -allotmentoption is exercised. (3)Includes 5,500,000 public shares, 1,375,000 Class B ordinary shares, 277,000 private placement shares underlying the private placement units and 247,500 Class A ordinary shares to be issued to Maxim and/or its designees. (4)Founder shares are classified as Class B ordinary shares, which shares will convert into Class A ordinary shares on a one -for -onebasis, subject to adjustment as described below adjacent to the caption “ Founder shares conversion and anti -dilution.”

26

| Founder shares |     | On December 13, 2024, we issued to our sponsor 1,581,250 founder shares for an aggregate purchase price of $25,000, or approximately $0.016 per share. Our sponsor intends to transfer an aggregate of 80,000 of its founder shares, or 20,000 each to our four directors and officers, upon consummation of an initial business combination. Our sponsor will own 20% of our issued and outstanding shares after this offering (assuming it does not purchase units in this offering and excluding the private placement shares and the Representative’s Shares). If we increase or decrease the size of the offering, we will effect a capitalization or share surrender or redemption or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our sponsor at 20% of our issued and outstanding ordinary shares upon the consummation of this offering (excluding the private placement shares and the Representative’s Shares). Up to 206,250 founder shares are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. |
|                |     | The nominal purchase price paid by our sponsor for the founder shares may significantly dilute the implied value of your public shares in the event we consummate an initial business combination, and our sponsor and other initial shareholder are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to decline materially. The following table sets forth information